CCL2 and Alzheimer disease: Another meta-analysis comprising 88 studies found increased levels of CRP, IL-1β, IL-2, IL-6, IL-12, IL-18, MCP-1, MCP 3, IL-8, and interferon-γ-inducible protein 10 (IP-10) in patients with AD [144].